Ceapro Inc. (CVE:CZO – Get Free Report) was down 11.8% during mid-day trading on Tuesday . The stock traded as low as C$0.23 and last traded at C$0.23. Approximately 5,849 shares were traded during trading, a decline of 88% from the average daily volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Price Performance
The stock has a market cap of C$17.62 million, a price-to-earnings ratio of -3.75 and a beta of 1.38. The company has a 50 day simple moving average of C$0.22 and a 200-day simple moving average of C$0.23. The company has a quick ratio of 18.88, a current ratio of 8.54 and a debt-to-equity ratio of 8.07.
Ceapro Company Profile
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Featured Stories
- Five stocks we like better than Ceapro
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- 3 REITs to Buy and Hold for the Long Term
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- What is the Euro STOXX 50 Index?
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
